The Pre-Filled Syringes Market Will Reach $6,940m In 2020 Predicts New Visiongain Report

10 September 2018
Pharma

A new report by visiongain predicts that the Pre-Filled Syringes market will reach $6,940m in 2020. This forecast and others appear in Pre-Filled Syringes Market Forecast 2016-2026: Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes published in April 2016. Visiongain is a business information provider based in London, UK.

The Pre-Filled Syringes Market Forecast 2016-2026 report examines the current and future trends in the growing pre-filled syringes market. Glass syringes have long dominated the market, however the improved characteristics of plastic syringes, an increasing adoption of autoinjectors and pen injectors, as well as the advent of needle-free delivery systems are posing a threat to the continued dominance of glass syringes. The large number of injectable drugs in the pipeline and increasing number of approved biosimilars is helping to spur demand for pre-filled syringes, despite newer oral therapies being much preferred by patients.

In this report, we examine in detail some of the main national markets in the market, analyse and forecast the major treatment areas that use pre-filled syringes, as well as forecast specific products that are delivered in pre-filled syringes. In addition, the report includes an in-depth discussion of the main companies in the market, including historical revenues and product details when available. Qualitative analysis of the market is given, taking into account governmental policy and regulation, safety, features and more.

Visiongain’s report provides revenue forecasts to 2026 for the Pre-Filled Syringes market, its leading national markets, therapeutics areas and products. The report discusses selected leading companies in the market. These companies include Becton, Dickinson and Company, Gerresheimer, Schott, Baxter, Nipro, Weigao, Unilife, Roselabs, SHL Group, Ypsomed, Haselmeier, Owen Mumford, Bespak and Datwyler.

Pre-Filled Syringes Market Forecast 2016-2026: Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.

Recent News

“In Vitro Diagnostics (IVD) market set to grow to $91bn by 2024” says new Visiongain report

In recent years, the IVD market has experienced increased consolidation among industry participants, with significant merger and acquisition (M&A) activity, especially among larger companies as they diversify and manoeuvre for stronger positions.

14 May 2019

Read

“Indian Pharmaceutical market set to grow to $71bn by 2024” says new Visiongain report

Expected increases in the level of healthcare coverage will allow greater proportion of the population to be able to afford medical care, which is still mostly paid for out-of-pocket by patients, as a greater amount of people have health insurance to cover their medical expenses.

09 May 2019

Read

“Global mRNA Vaccines and Therapeutics market set to grow to $5.5bn by 2024” says new Visiongain

The major drivers supporting the growth of the mRNA Vaccines and Therapeutics Market are rising adoption of personalized medicine for effective treatment, advantages offered by mRNA-based products, and rising funding by pharmaceutical companies and government organizations.

07 May 2019

Read

“Global Oncology Drugs market set to grow to $173bn by 2024” says new Visiongain report

The cancer treating drugs market will continue to grow over the next ten years.

03 May 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever
WOOCS 2.2.1